arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Organon & Co.

OGN

$13.61 ▲ +0.07 (+0.52%) at close

8 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

Organon & Co. shows mixed fundamentals. However, watch Debt to Equity which shows concerning trends. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $3.5B

Dividend Yield 2.50%

Revenue Growth -2.9% ↘

Op. Margin —

ROIC —

FCF / Share $2.07 ↘

Trailing P/E 18.9x

Price / Book 4.7x

FCF Yield 15.2%

Debt / Equity 11.49

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$6.22B

↓ -2.9% —

Net Income Profit after all expenses

$187.00M

↓ -78.4% —

FCF / Share Free cash flow per share

$2.07

↓ -30.2% —

Long-Term Debt Long-term obligations

$8.64B

↓ -2.7% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↓

Returns ↓

Financial Health

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$0.34 Latest / share

-69.6% YoY

-11.7% 5-yr CAGR

FY 2018

FY 2019

FY 2020

$0.56

FY 2021

$1.12

FY 2022

$1.12

FY 2023

$1.12

FY 2024

$0.34

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-2.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-137%)	2.2% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-72%)	1.4% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-82%)	-2.1% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-126%)	-3.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-144%)	-16.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-300%)	—	—
EPS Growth YoY (%)	-78.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-16.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	11.1% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-32.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-37.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-32.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-78.4% Weak ↓ Weak Declining Year-over-year change in net income	-15.5% Weak ↑ Weak Improving Year-over-year change in net income	11.6% Fair ↑ Fair Improving Year-over-year change in net income	-32.1% Weak ↑ Weak Improving Year-over-year change in net income	-37.5% Weak Weak Year-over-year change in net income	-32.9% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-30.2% Weak Weak Year-over-year change in free cash flow	38.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—
Revenue CAGR 3Y (%)	0.2% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	0.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-1.4% Weak Weak Compound annual revenue growth over 3 years	-7.4% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-1.0% Weak Weak Compound annual revenue growth over 5 years	-3.8% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	-41.6% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-14.3% Weak ↑ Weak Improving Compound annual EPS growth over 3 years	-22.2% Weak Weak Compound annual EPS growth over 3 years	-34.2% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Effective Tax Rate (%) (%)	56.0% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-7.1% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	-52.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.3% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	11.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.0% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	10.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	3.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-75%)	13.5% Fair ↓ Fair Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+12%)	16.3% Good ↓ Good Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+36%)	14.9% Fair ↓ Fair Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+24%)	21.4% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+79%)	33.1% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+176%)	41.4% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+245%)	—
FCF Margin (%) (%)	8.7% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	11.9% Fair Fair Free cash flow as a percentage of revenue Optimal: > 10%	8.7% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	2.88x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Common Equity (%) (%)	24.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+66%)	183.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1120%)	—	-102.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-785%)	-89.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-697%)	39.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+162%)	45.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+205%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	11.49x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1816%)	18.81x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+3036%)	-125.14x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-20957%)	-9.99x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1765%)	-6.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1110%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—
Net Debt (USD)	$8.07B	$8.21B	$8.07B	$8.21B	$8.40B	$-12.00M	—	—

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$23.95	$24.91	$24.54	$24.30	$24.86	$25.77	$30.68	—
Basic EPS, GAAP (USD)	$0.72	$3.36	$4.01	$3.61	$5.33	$8.52	$12.69	—
Free Cash Flow per Share (USD)	$2.07	$2.97	$2.15	—	—	—	—	—
Dividend per Share (USD)	$0.34	$1.12	$1.12	$1.12	$0.56	—	—	—
Book Value per Share (USD)	$2.89	$1.83	$-0.27	$-3.51	$-5.95	$21.64	$27.75	—
Tangible Book Value per Share (USD)	$-17.41	$-21.81	$-18.28	$-21.60	$-24.10	$3.48	$27.75	—
Basic Weighted Avg Shares (shares)	259.50M	257.05M	255.24M	254.08M	253.54M	253.52M	253.52M	—
Dividend Payout Ratio (%)	47.2% Good ↑ Good Improving Dividends paid as a percentage of earnings Optimal: 30-60%	33.3% Good ↑ Good Improving Dividends paid as a percentage of earnings Optimal: 30-60%	27.9% Excellent ↑ Excellent Improving Dividends paid as a percentage of earnings Optimal: 30-60%	31.0% Good Good Dividends paid as a percentage of earnings Optimal: 30-60%	10.5% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$1.96B	$1.63B	$1.59B	$1.42B	$1.16B	$894.00M	—	—
LT Debt (USD)	$8.64B	$8.88B	$8.76B	$8.91B	$9.13B	$0.00	—	—
Total Equity (USD)	$752.00M	$472.00M	$-70.00M	$-892.00M	$-1.51B	$5.49B	$7.04B	$6.35B

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$6.22B	$6.40B	$6.26B	$6.17B	$6.30B	$6.53B	$7.78B	—
Depreciation Expense (USD)	$156.00M	$132.00M	$120.00M	$96.00M	$92.00M	$56.00M	$49.00M	—
Net Income, GAAP (USD)	$187.00M	$864.00M	$1.02B	$917.00M	$1.35B	$2.16B	$3.22B	—
Operating Cash Flow (USD)	$700.00M	$939.00M	$799.00M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 28 quarters

Organon & Co.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare OGN with peers